REQUOLIS Trademark

Trademark Overview


On Tuesday, December 3, 2019, a trademark application was filed for REQUOLIS with the United States Patent and Trademark Office. The USPTO has given the REQUOLIS trademark a serial number of 79278870. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, September 22, 2022. This trademark is owned by Novartis AG. The REQUOLIS trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the preven...
requolis

General Information


Serial Number79278870
Word MarkREQUOLIS
Filing DateTuesday, December 3, 2019
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, September 22, 2022
Registration Number6082594
Registration DateTuesday, June 23, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 7, 2020

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, September 22, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Wednesday, April 12, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Tuesday, April 11, 2023DEATH OF INTERNATIONAL REGISTRATION
Friday, October 2, 2020NOTIFICATION PROCESSED BY IB
Sunday, September 6, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, August 28, 2020FINAL DISPOSITION PROCESSED
Thursday, July 23, 2020GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, June 23, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, April 7, 2020PUBLISHED FOR OPPOSITION
Wednesday, March 18, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 18, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 18, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, March 18, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 18, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 18, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 18, 2020NOTICE OF PUBLICATION
Friday, February 28, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 27, 2020ASSIGNED TO EXAMINER
Tuesday, February 25, 2020APPLICATION FILING RECEIPT MAILED
Wednesday, February 19, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 15, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, February 13, 2020SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB